Upgrade to SI Premium - Free Trial

Nexalin Technology, Inc (NXL)

4.99 +0.17 (3.53%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV September 11, 2026 9:01 AM - StreetInsider Form 8-K Nexalin Technology, Inc. For: Aug 26 August 27, 2026 7:30 AM - SEC Filing Nexalin Technology enacts 1-for-30 reverse stock split on Nasdaq August 27, 2026 7:25 AM - StreetInsider Nexalin Technology Announces Reverse Stock Split August 27, 2026 7:25 AM - StreetInsider Form SCHEDULE 13G Nexalin Technology, Inc. Filed by: Alumni Capital LP August 27, 2026 6:15 AM - SEC Filing Form 8-K Nexalin Technology, Inc. For: Aug 21 August 21, 2026 5:20 PM - SEC Filing Form 8-K Nexalin Technology, Inc. For: Aug 19 August 20, 2026 5:29 PM - SEC Filing Form 424B5 Nexalin Technology, Inc. August 20, 2026 5:24 PM - SEC Filing Form 8-K Nexalin Technology, Inc. For: Aug 14 August 17, 2026 9:00 AM - SEC Filing Form 10-Q Nexalin Technology, Inc. For: Jun 30 August 12, 2026 5:13 PM - SEC Filing Form 8-K Nexalin Technology, Inc. For: Aug 11 August 11, 2026 4:16 PM - SEC Filing Form 8-K Nexalin Technology, Inc. For: Jul 28 July 29, 2026 5:25 PM - SEC Filing Form 8-K Nexalin Technology, Inc. For: Jul 24 July 27, 2026 5:25 PM - SEC Filing Form ARS Nexalin Technology, Inc. For: Dec 31 July 10, 2026 4:31 PM - SEC Filing Form DEF 14A Nexalin Technology, Inc. For: Aug 11 July 10, 2026 4:30 PM - SEC Filing Form PRE 14A Nexalin Technology, Inc. For: Jun 29 June 29, 2026 5:30 PM - SEC Filing Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company’s Proprietary DIFS™ Platfor June 23, 2026 8:30 AM - StreetInsider Form 8-K Nexalin Technology, Inc. For: Jun 16 June 17, 2026 5:00 PM - SEC Filing NEXALIN abstracts accepted at 2026 NYC Neuromodulation Conference June 16, 2026 9:15 AM - StreetInsider Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia June 16, 2026 9:15 AM - StreetInsider Full Article List